Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

Table 2 Patient Characteristics

	Response after 2 courses of platinum-based chemotherapy
	PR (n = 37) (%)	SD (n = 117) (%)	P
Age, year, median	56	57	0.286
Sex, %
Female	15(41%)	47(40%)	0.968
Male	22(59%)	70(60%)
Stage, %
IIIB	13(35%)	44(38%)	0.786
IV	24(65%)	73(62%)
ECOG performance status, %
0	25(68%)	59(50%)	0.068
1	12(32%)	58(50%)
Weight loss ≥5%, %	14(38%)	50(43%)	0.598

PR Partial Response; SD Stable Disease; ECOG Eastern Cooperative Oncology Group.

ISSN: 1471-2407